3 Followers USX:ATOS - Atossa Therapeutics Inc Atossa Genetics Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 13 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 1.83    +0.03 (+1.67%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

27 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.

IPO: 2012-11-08

Headquarters: US

Employees: 11

Homepage

Description

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms